FJ.HOOK
ALN Optional Vena Cava Filter, Jugular
$249.00
box of 1
In Stock: 10 Eaches
Expiration:
Expired
Express: Need it tomorrow? Order in next 2 hours 8 minutes and choose overnight shipping at checkout.
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in-date item only.
Medtronic Biosyn undyed 30" C-13 cutting
$5.00 packets
Medtronic Biosyn undyed 18" P-12 Reverse Cutting Needle
$8.00 packets
Medtronic Biosyn undyed 30" CV-23 taper
$89.00 box of 36
Medtronic Monosof black 60" GS-26 taper
$7.00 packets
Medtronic Monosof black 8" SE-CC-6 spatula, double armed
$30.00 packets
Medtronic Biosyn undyed 27" GS-21 taper
$159.50 box of 36
Medtronic Monosof black 30" SC-2 cutting
$2.55 packets
Additional information
| Size | 1 |
|---|---|
| Arms | N/A |
| Manufacturer | |
| Type | Vena Cava |
| Unit | box of 1 |
- FDA Product Code: DTK
- FDA Product Code Name: Filter, Intravascular, Cardiovascular
- GMDN Term Code: 44864
- GMDN Term Name: Vena cava filter, temporary/permanent
- GMDN Term Description: A vascular device intended to be percutaneously implanted in the inferior vena cava (IVC) to prevent pulmonary embolism (PE); it can be retrieved before a threshold period or remain as a permanent implant after the period. It achieves its unconstrained diameter upon deployment in the IVC and imparts an outward radial force on the luminal surface of the vena cava to ensure proper positioning and stability. It is designed for blood clot capture while maintaining caval patency. It is made of metal alloys [e.g., stainless steel, titanium (Ti), nickel-titanium alloy (Nitinol)] and is available in various self-expanding designs (e.g., conical, basket). This is a single-use device.
Bard PV
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.